BPCR - BioPharma Credit PLC - Stock & Dividends

Exchange: London Exchange • Country: United Kingdom • Currency: USD • Type: Common Stock • ISIN: GB00BDGKMY29

Loans, Royalties, Debt, Securities, Pharmaceuticals

BioPharma Credit PLC is a unique investment trust that focuses on generating returns through interest-bearing debt assets. These debt assets are carefully selected and secured by royalties or other cash flows derived from the sales of approved life sciences products, providing a stable source of income.

The company's investment strategy is centered around providing financing solutions to pharmaceutical and biotechnology companies, allowing them to access capital while sharing the risks and rewards of their innovative products. By doing so, BioPharma Credit PLC is able to tap into the growing demand for life sciences investments, while also providing a diversified portfolio of debt assets.

As a London-based company, incorporated in 2016, BioPharma Credit PLC is well-positioned to leverage its expertise in the life sciences sector, as well as its access to the global debt markets. The company's investment team has a deep understanding of the complex dynamics of the pharmaceutical and biotechnology industries, enabling them to identify and invest in debt assets that offer attractive returns while minimizing risk.

For investors seeking a unique investment opportunity that combines the stability of debt assets with the growth potential of the life sciences sector, BioPharma Credit PLC offers an attractive proposition. With its strong track record and experienced investment team, the company is well-placed to continue delivering returns to its shareholders while contributing to the development of innovative life sciences products.

For more information about BioPharma Credit PLC, please visit their website at https://www.bpcruk.com.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for BPCR - BioPharma Credit PLC  - Stock & Dividends

BPCR Stock Overview

Market Cap in USD 105,388m
Sector Financial Services
Industry Asset Management
GiC SubIndustry Asset Management & Custody Banks
TER 0.00%
IPO / Inception

BPCR Stock Ratings

Growth 5y 79.1
Fundamental 28.3
Dividend 87.4
Rel. Performance vs Sector -1.98
Analysts -
Fair Price Momentum 1.00 USD
Fair Price DCF 2.57 USD

BPCR Dividends

Dividend Yield 12m 21.15%
Yield on Cost 5y 30.32%
Dividends CAGR 5y 8.06%
Payout Consistency 95.0%

BPCR Growth Ratios

Growth 12m 21.21%
Growth Correlation 12m 73%
Growth Correlation 3m 16.1%
CAGR 5y 7.65%
CAGR/Mean DD 5y 2.50
Sharpe Ratio 12m 1.13
Alpha vs SP500 12m 11.67
Beta vs SP500 5y weekly 0.13
ValueRay RSI 30.23
Volatility GJR Garch 1y 14.60%
Price / SMA 50 -2.27%
Price / SMA 200 2.38%
Current Volume 763.5k
Average Volume 20d 1435.7k

External Links for BPCR Stock

Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of BPCR stocks?
As of October 22, 2024, the stock is trading at USD 0.86 with a total of 763,474 shares traded.
Over the past week, the price has changed by -1.14%, over one month by -0.48%, over three months by +2.22% and over the past year by +21.50%.
What are the forecast for BPCR stock price target?
According to ValueRays Forecast Model, BPCR BioPharma Credit PLC will be worth about 1.1 in October 2025. The stock is currently trading at 0.86. This means that the stock has a potential upside of +25.58%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 1.1 25.6